SB
SLAM BioTherapeutics, Inc.
SEC filingBiotechnology · Westlake Village, CA
Amount raised$1Msold at filing
Total offering$4M$3M still open
Investors in the raise1count reported to the SEC
FiledDec 29, 2025first sale Dec 19, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Richard HeinickExecutive Officer, Director
Ted SchwartzDirector
Steve PazolDirector
Mark HaglerDirector
David VennettilliDirector
Executive officers, directors and promoters as listed on the Form D.